Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagus

Tumori

Volumn 87, Issue 5, 2001, Pages 299-302

  Bidoli, P ^a   Stani, S C ^a   De Candis, D ^a   Cortinovis, D ^a   Parra, H S ^a   Bajetta, E ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Esophagus; Squamous cell carcinoma; Vinorelbine

Indexed keywords

CISPLATIN; FLUOROURACIL; NAVELBINE; VINCA ALKALOID;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DRUG RESPONSE; DYSPHAGIA; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MALE; METASTASIS; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; SQUAMOUS CELL CARCINOMA;

EID: 0035201105     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160108700504     Document Type: Article

References (11)

1. Oesophageal cancer treatment: Studies, strategies and facts
2. Surgical management of esophageal carcinoma
3. Surgical therapy of esophageal carcinoma
4. Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus
5. Treatment of locally advanced squamous cell carcinoma of the oesophagus
6. Chemotherapy in esophageal cancer
7. Vinorelbine: An overview
8. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus
9. Vindesine in the treatment of esophageal carcinoma: A phase II study
10. Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma